← Evidence map

ArticleInfectious diseases and therapy2023

Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.

Santiago Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2023
2024
2025
2026
this papercites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 37452174